Anshul Maheshwari net worth and biography

Anshul Maheshwari Biography and Net Worth

CFO of SiBone

Anshul Maheshwari joins SI-BONE with over 15 years of experience in corporate finance, banking, treasury, and strategy. Most recently, Mr. Maheshwari served as Vice President of Finance, Investor Relations and Treasurer for Varian Medical Systems, a leading cancer care platform, where he held roles of increasing responsibilities since 2018. Prior to joining Varian Medical Systems, Mr. Maheshwari was Assistant Treasurer for Bechtel Corporation, a leading engineering and construction company. Prior to that, Mr. Maheshwari spent the majority of his career at Bank of America in corporate and investment banking.

What is Anshul Maheshwari's net worth?: The estimated net worth of Anshul Maheshwari is at least $3.26 million as of February 17th, 2026. Mr. Maheshwari owns 266,466 shares of SiBone stock worth more than $3,262,876 as of March 30th. This net worth estimate does not reflect any other assets that Mr. Maheshwari may own. Learn More about Anshul Maheshwari's net worth.
How do I contact Anshul Maheshwari?: The corporate mailing address for Mr. Maheshwari and other SiBone executives is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. SiBone can also be reached via phone at (408) 207-0700 and via email at [email protected]. Learn More on Anshul Maheshwari's contact information.
Has Anshul Maheshwari been buying or selling shares of SiBone?: During the past quarter, Anshul Maheshwari has sold $433,582.92 in shares of SiBone stock. Most recently, Anshul Maheshwari sold 21,528 shares of the business's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $15.37, for a transaction totalling $330,885.36. Following the completion of the sale, the chief financial officer now directly owns 266,466 shares of the company's stock, valued at $4,095,582.42. Learn More on Anshul Maheshwari's trading history.
Who are SiBone's active insiders?: SiBone's insider roster includes Jeffrey Dunn (Director), Laura Francis (CEO), John Freund (Director), Jeryl Hilleman (Director), Gregory Hinckley (Director), E Jr (Director), Anshul Maheshwari (CFO), Mika Nishimura (Director), Michael Pisetsky (SVP), and Anthony Recupero (Insider). Learn More on SiBone's active insiders.
Are insiders buying or selling shares of SiBone?: In the last year, insiders at the sold shares 52 times. They sold a total of 521,413 shares worth more than $9,102,397.27. The most recent insider tranaction occured on March, 12th when Director Mika Nishimura sold 4,100 shares worth more than $56,703.00. Insiders at SiBone own 4.0% of the company. Learn More about insider trades at SiBone.
Information on this page was last updated on 3/12/2026.

Anshul Maheshwari Insider Trading History at SiBone

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/17/2026	Sell	21,528	$15.37	$330,885.36	266,466
1/2/2026	Sell	5,229	$19.64	$102,697.56	180,002
12/18/2025	Sell	18,542	$20.15	$373,621.30	185,231
11/25/2025	Sell	100	$20.00	$2,000.00	203,773
11/21/2025	Sell	1,200	$20.01	$24,012.00	203,873
11/17/2025	Sell	3,460	$17.43	$60,307.80	205,073
11/11/2025	Sell	2,601	$18.33	$47,676.33	208,533
10/2/2025	Sell	3,311	$14.20	$47,016.20	211,134
8/18/2025	Sell	3,461	$15.57	$53,887.77	214,445
7/2/2025	Sell	5,005	$18.34	$91,791.70	217,078
5/19/2025	Sell	2,424	$19.48	$47,219.52	222,083
5/16/2025	Sell	9,585	$19.76	$189,399.60	224,507
5/12/2025	Sell	4,937	$19.02	$93,901.74	232,069
5/7/2025	Sell	4,937	$17.00	$83,929.00	265,356
1/2/2025	Sell	5,304	$13.91	$73,778.64	189,319
11/18/2024	Sell	2,439	$12.68	$30,926.52	194,623
9/3/2024	Sell	1,414	$16.35	$23,118.90	200,367
8/16/2024	Sell	2,418	$13.87	$33,537.66	198,762
5/16/2024	Sell	2,441	$15.14	$36,956.74	204,241
4/2/2024	Sell	2,425	$15.45	$37,466.25	205,516
1/2/2024	Sell	1,470	$20.92	$30,752.40	147,268
11/16/2023	Sell	1,733	$17.59	$30,483.47	148,738
10/2/2023	Sell	1,244	$21.15	$26,310.60	150,471
8/16/2023	Sell	1,733	$20.98	$36,358.34	151,715
7/3/2023	Sell	1,244	$26.70	$33,214.80	153,448
6/7/2023	Sell	3,272	$28.00	$91,616.00	154,692
5/16/2023	Sell	3,624	$24.48	$88,715.52	157,964
4/3/2023	Sell	1,229	$19.30	$23,719.70	159,697
2/28/2023	Sell	1,986	$21.00	$41,706.00	160,926
2/16/2023	Sell	3,212	$16.82	$54,025.84	162,912
8/16/2022	Sell	1,709	$17.29	$29,548.61	89,487
5/16/2022	Sell	4,111	$12.58	$51,716.38	90,748

Anshul Maheshwari Buying and Selling Activity at SiBone

SiBone Company Overview

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Today's Range

Now: $12.25

$12.15

$12.49

50 Day Range

MA: $15.02

$12.29

$17.14

2 Week Range

Now: $12.25

$12.15

$21.89

Volume

181,914 shs

Average Volume

580,172 shs

Market Capitalization

$541.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69